查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439582

经导管二尖瓣修復装置 - 全球市场回顾、竞争格局、市场预测（2030）

Transcatheter Mitral Valve Repair Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

2023年全球经导管二尖瓣修復器材市场规模将达11.9706亿美元，到2030年将达到27.5671亿美元，复合年增长率预计为14.95%。 经导管二尖瓣修復装置的需求主要是由于二尖瓣狭窄、二尖瓣脱垂和二尖瓣逆流等心臟瓣膜疾病的日益流行所推动的。 此外，预计2024年至2030年冠状动脉疾病、心肌梗塞、充血性心臟衰竭和心绞痛等心血管疾病的盛行率将增加，产品开发的技术创新以及产品上市和批准的增加将有助于整体成长在此期间的经导管二尖瓣修復装置市场。

经导管二尖瓣修復装置的市场动态

受多种因素影响，经导管二尖瓣修復装置市场的产品需求正在增长，其中主要因素之一是二尖瓣狭窄、二尖瓣脱垂、二尖瓣关闭不全等。心臟瓣膜疾病的患病率不断增加。

英国心臟基金会(BHF) 预测，到2023 年，由于生活方式的改变、老化和人口增长，到2022 年，全球将有大约5.5 亿人患有心臟病和循环系统疾病。我报告过。

此外，根据世界卫生组织 (WHO) (2020) 的数据，全球有 900 万人患有钙化主动脉瓣狭窄。 此外，根据John Muir Health的统计，2020年美国约有150万人受到主动脉瓣狭窄的影响，其中约50万人患有严重主动脉瓣狭窄。 据同一消息来源称，2020年，美国约有25万名主动脉瓣狭窄患者出现症状。 因此，包括各种心臟瓣膜疾病在内的心血管疾病的盛行率不断增加，增加了对经导管二尖瓣修復装置的需求。

患者对微创手术的偏好不断增加，预计也预示着预测期内市场的成长。 经导管二尖瓣修復装置以微创方式提供优于传统手术的优势，包括更快的恢復时间、更少的手术后疼痛、更短的住院时间、更少的伤口併发症和更好的伤口假体。

此外，产品发布和批准的增加将对市场产生积极影响。 例如，2019年3月，美国食品药物管理局（FDA）批准了由雅培公司开发的MitraClip。 该装置用作心臟瓣膜修復装置，以缓解中度至重度或重度二尖瓣逆流。 这是一种微创医疗程序，需要 1 至 3 小时。

因此，上述因素将有助于 2024-2030 年预测期内经导管二尖瓣修復装置市场的成长。

然而，在 2024-2030 年预测期内，与经导管二尖瓣修復相关的风险可能会抑制经导管二尖瓣修復器械市场的成长。

随着封锁法规的实施作为遏制 COVID-19 传播的必要措施，经导管二尖瓣修復装置市场经历了暂时的衰退。 由于入院和诊所接受心臟手术等手术的患者人数下降，对经导管二尖瓣修復装置的需求受到阻碍。 此外，由于严格的封锁规则和资源缺乏，製造和研发活动已经停止。 然而，随着活动的恢復、世界各地疫苗的接种以及患者从医院诊断和心臟手术中康復，对经导管二尖瓣修復装置的需求显着增加。 因此，预计上述因素将推动大流行期间对经导管二尖瓣修復装置的需求，并且在预测期内该需求将会成长。

经导管二尖瓣修復装置细分市场分析

就经导管二尖瓣修復装置市场的产品细分而言，生物组织瓣膜类别预计将在 2023 年获得可观的收入份额。 这是由于该部分提供的好处以及二尖瓣逆流盛行率的增加。

本报告提供了全球经导管二尖瓣修復装置市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第1章经导管二尖瓣修復装置市场报告简介

第2章经导管二尖瓣修復装置市场执行摘要

  • 调查范围
  • 市场概览
  • 竞争评估

第3章监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第4章经导管二尖瓣修復器材市场主要因素分析

  • 经导管二尖瓣修復装置市场驱动因素
    • 瓣膜性心臟病的盛行率不断上升
    • 人们对微创手术的兴趣与日俱增
  • 经导管二尖瓣修復器材市场的限制与挑战
    • 术后併发症的风险
  • 经导管二尖瓣修復装置的市场机会
    • 管道中存在大量恢復设备

第5章波特五力分析经导管二尖瓣修补器材市场

第6章经导管二尖瓣修復器材市场布局

  • 依类型
    • 机械阀
    • 生物组织（生物）瓣膜
  • 依指示
    • 二尖瓣关闭不全
    • 二尖瓣狭窄
    • 其他
  • 按最终用户
    • 医院、诊所
    • 门诊手术中心
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他领域

第7章经导管二尖瓣修復器材市场公司及产品概况

  • Abbott
  • Edwards Lifesciences Corporation.
  • Shockwave Medical, Inc.
  • LivaNova PLC
  • NeoChord, Inc.
  • Coramaze Technologies
  • CryoLife, Inc.
  • Auto Tissue Berlin GmbH.
  • Medtronic
  • Boston Scientific Corporation
  • JenaValve Technology, Inc

第8章KOL浏览量

第 9 章专案方法

第 10 章关于 DelveInsight

第 11 章免责声明与联络我们

Product Code: DIMDCL0411

Transcatheter Mitral Valve Repair Devices Market By Product (Mechanical Valve And Bioprosthetic Tissue Valve), Indication (Mitral Valve Regurgitation, Mitral Valve Stenosis, And Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of heart valve diseases and the growing demand for minimally invasive surgeries across the globe

The global transcatheter mitral valve repair devices market was valued at USD 1,197.06 million in 2023, growing at a CAGR of 14.95% during the forecast period from 2024 to 2030 to reach USD 2,756.71 million by 2030. The demand for transcatheter mitral valve repair devices is primarily being boosted by the increasing prevalence of heart valve diseases such as mitral valve stenosis, mitral valve prolapse, mitral valve regurgitation, and others. Further, the increasing prevalence of coronary artery disease, myocardial infarction, congestive heart failures, angina pectoris, and other cardiovascular diseases, along with innovation in product development and rising product launches and approvals are thereby contributing to the overall growth of the transcatheter mitral valve repair devices market during the forecast period from 2024-2030.

Transcatheter Mitral Valve Repair Devices Market Dynamics:

The transcatheter mitral valve repair devices market is witnessing a growth in product demand owing to various factors, one of the key factors being the increase in the prevalence of heart valve diseases such as mitral valve stenosis, mitral valve prolapse, mitral valve regurgitation, and others.

According to the British Heart Foundation (BHF), it was reported in 2023, that around 550 million people in 2022 were living with heart and circulatory diseases across the world owing to changing lifestyles, aging, and a growing population.

Further, according to the World Health Organization (WHO) 2020, the prevalence of calcific aortic valve stenosis was 9 million across the world. Also, as per the John Muir Health statistics, in the year 2020, about 1.5 million people in the United States suffered from aortic stenosis, and about 500,000 people within this group of patients suffered from severe aortic stenosis. As per the same source in 2020, about 250,000 patients suffering from aortic stenosis were symptomatic in the United States. Thus, the increasing prevalence of cardiovascular diseases including various heart valve diseases will increase the demand for transcatheter mitral valve repair devices.

The increasing patient preference for minimally invasive surgeries is also likely to bode well for the market growth during the forecast period. Transcatheter mitral valve repair devices offer advantages over conventional surgeries owing to their minimally invasive approach, such as shorter recovery time, less post-operational pain, less stay at the hospital, fewer wound complications, and better wound prosthesis.

Further, the rising product launches and approvals will create a positive impact on the market. For instance, in March 2019, the US Food and Drug Administration (FDA) approved MitraClip, developed by Abbott. The device is used as a heart valve repair device that was intended to reduce moderate-to-severe or even severe mitral regurgitation. It is a minimally invasive medical procedure and takes only 1-3 hours.

Therefore, the above-mentioned factors are contributing to the growth of the Transcatheter mitral valve repair devices market during the forecast period from 2024-2030.

However, risks associated with transcatheter mitral valve repair procedures and others may restrict the transcatheter mitral valve repair devices' market growth during the forecast period from 2024-2030.

The transcatheter mitral valve repair devices market experienced a period of a temporary setback as lockdown restrictions were enforced as a necessary step to curb the spread of COVID-19. The demand for transcatheter mitral valve repair devices was disrupted owing to the decline in the number of patients in hospitals & clinics for surgeries such as cardiac surgery. Moreover, manufacturing and research & development activities were halted owing to the imposition of strict lockdown rules and due to a lack of resources. However, with the resumption of various activities and with the administration of vaccines across different regions of the world, the demand for transcatheter mitral valve repair devices increased significantly with the resumption of patients in hospitals for diagnosis and heart surgeries. Henceforth, the aforementioned factors propelled the demand for transcatheter mitral valve repair devices during the pandemic and are estimated to grow similarly during the forecast period.

Transcatheter Mitral Valve Repair Devices Market Segment Analysis:

Transcatheter Mitral Valve Repair Devices Market by Product (Mechanical Valve and Bioprosthetic Tissue Valve), Indication (Mitral Valve Regurgitation, Mitral Valve Stenosis, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the transcatheter mitral valve repair devices market, the bioprosthetic tissue valve category is expected to amass significant revenue share in the year 2023. This can be ascribed to the advantages offered by the segment and the increasing prevalence of mitral valve regurgitation cases.

Bioprosthetic valves commonly used in clinical practice are called heterografts, which are usually stented or stentless porcine or bovine tissue valves. The bioprosthetic tissue valve category has higher efficacy as compared to the mechanical valve. The main advantage of bioprosthetic valves is that they do not require lifelong warfarin therapy, due to their lower thrombotic risk compared with mechanical valves.

Also, patients with bioprosthetic valves have a significantly decreased risk of bleeding.

Further, the increasing prevalence of heart valve diseases will increase the demand for bioprosthetic tissue valve devices. For instance, according to the Centers for Disease Control and Prevention (CDC) (2019), it was reported that in 2019, about 2.5% of the US population had valvular heart disease, being more common among the older population. Thus, the growing prevalence of valvular heart disease is expected to increase the demand for bioprosthetic tissue valve devices, thereby increasing the overall market growth.

Further, the increasing product launches and approvals and other strategic activities will in turn propel the demand for bioprosthetic tissue valve devices. For instance, in September 2021, Abbott received US FDA approval for Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people suffering from aortic or mitral valve disease. Epic Plus, a bioprosthetic valve, do not require long-term use of blood-thinner medication, making them the recommended option for people, especially aged over 70 years who are at risk of taking blood thinners.

Therefore, the advantages offered by bioprosthetic tissue valve devices along with the rising product launches are predicted to contribute to the increasing demand for this category, thereby driving the growth of the overall transcatheter mitral valve repair devices market during the forecast period.

North America is expected to dominate the overall Transcatheter Mitral Valve Repair Devices Market:

Among all the regions, North America is estimated to account for the largest share of the transcatheter mitral valve repair devices market in the year 2023. Owing to the factors such as the rising prevalence of heart valve diseases such as mitral valve stenosis, mitral valve prolapses, and mitral valve regurgitation. Apart from this, rising incidences of cardiovascular diseases such as strokes, and coronary artery diseases, among others, the rising burden of elderly patients prone to cardiovascular diseases, rising product approvals and launches, and escalating technological advancements are driving the North America transcatheter mitral valve repair devices market and is expected to witness positive growth.

According to the Canadian Cardiovascular Society (2023), it was reported that in 2022, 2.5% of the population had heart valve diseases, which is increasing significantly after the age of 65, reaching up to 13% after the age of 75. It was also estimated by the same source that in 2040, Canada will have an estimated 1.5 million people over 65 years with heart valve disease (HVD).

According to CDC (2019), it was reported that each year, about 805,000 people in the United States had a heart attack. Also, according to American Heart Association (2023), 20% of older Americans suffer from aortic stenosis, a common valve disease, each year.

Therefore, in such cases, transcatheter mitral valve repair device systems prove to be beneficial for the treatment of large patient pools suffering from heart valve diseases and other cardiovascular diseases, hence driving the demand and overall regional market of transcatheter mitral repair devices during the forecast period (2024-2030).

Coupled with the factors mentioned above, the increasing planned activities by the key players will also drive the market of transcatheter mitral valve repair devices. For instance, in September 2022, Edwards Lifesciences received FDA approval for its Pascal Precision system. The device used minimally invasive surgery to repair the mitral valve in patients with degenerative mitral regurgitation, a condition where the valve between heart chambers does not close completely, allowing blood to leak back through. Thus, such strategic steps help to increase the demand for transcatheter mitral valve repair devices, thereby driving the North America transcatheter mitral valve repair devices market forward during the forecast period.

Transcatheter Mitral Valve Repair Devices Market Key Players:

Some of the key market players operating in the transcatheter mitral valve repair devices market include Abbott, Edwards Lifesciences Corporation., Shockwave Medical, Inc., LivaNova PLC, NeoChord, Inc., Coramaze Technologies, CryoLife, Inc., Auto Tissue Berlin GmbH., Medtronic, Boston Scientific Corporation, JenaValve Technology, Inc., and others.

Recent Developmental Activities in the Transcatheter Mitral Valve Repair Devices Market:

In January 2023, Shockwave Medical, Inc., acquired Neovasc Inc., a company focused on the minimally invasive treatment of refractory angina, which is a chronic condition wherein a patient suffers chest pain that cannot be controlled by conventional therapies.

In January 2020, Abbott received CE Mark for its Tendyne Transcatheter Mitral Valve Implantation (TMVI) system for the treatment of mitral regurgitation (MR) in patients requiring a heart valve replacement and provides a safer option for candidates not willing to opt for open-heart surgery or transcatheter mitral valve repair.

Key Takeaways from the Transcatheter Mitral Valve Repair Devices Market Report Study

Market size analysis for current transcatheter mitral valve repair devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the transcatheter mitral valve repair devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global transcatheter mitral valve repair devices market.

Various opportunities available for the other competitor in the transcatheter mitral valve repair devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current transcatheter mitral valve repair devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for transcatheter mitral valve repair devices market growth in the coming future?

Target Audience who can be benefited from this Transcatheter Mitral Valve Repair Devices Market Report Study

Transcatheter mitral valve repair devices products providers

Research organizations and consulting companies

Transcatheter mitral valve repair devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in transcatheter mitral valve repair devices

Various End-users who want to know more about the transcatheter mitral valve repair devices market and the latest technological developments in the transcatheter mitral valve repair devices market.

Frequently Asked Questions for the Transcatheter Mitral Valve Repair Devices Market:

1. What are transcatheter mitral valve repair devices?

Transcatheter mitral valve repair devices are cardiac surgical devices that are used to treat heart valve diseases such as regurgitation, stenosis, and prolapse. Transcatheter mitral valve treatment is a minimally invasive procedure to replace a mitral valve that is not working properly.

2. What is the market for global transcatheter mitral valve repair devices?

The global transcatheter mitral valve repair devices market was valued at USD 1,197.06 million in 2023, growing at a CAGR of 14.95% during the forecast period from 2024 to 2030 to reach USD 2,756.71 million by 2030.

3. What are the drivers for the global transcatheter mitral valve repair devices market?

The demand for transcatheter mitral valve repair devices is primarily being heightened by the increasing prevalence of heart valve diseases, increasing prevalence of coronary artery disease, myocardial infarction, congestive heart failures, angina pectoris, and others. In addition, rising awareness and demand for minimally invasive devices, the increasing novel product launches and approvals, and innovation in product development thereby contribute to the overall growth of the transcatheter mitral valve repair devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global transcatheter mitral valve repair devices market?

Some of the key market players operating in the transcatheter mitral valve repair devices market include Abbott, Edwards Lifesciences Corporation., Shockwave Medical, Inc., LivaNova PLC, NeoChord, Inc., Coramaze Technologies, CryoLife, Inc., Auto Tissue Berlin GmbH., Medtronic, Boston Scientific Corporation, JenaValve Technology, Inc., and others.

5. Which region has the highest share in the transcatheter mitral valve repair devices market?

North America is expected to dominate the overall transcatheter mitral valve repair devices market during the forecast period from 2024-2030. Factors such as the rising prevalence of heart valve diseases, the increasing geriatric population prone to cardiovascular diseases, the rising number of risk factors, collaborations, acquisitions, partnerships among key market players in the market, and other factors are expected to drive the growth of the North American transcatheter mitral valve repair devices market.

Table of Contents

1.Transcatheter Mitral Valve Repair Devices Market Report Introduction

2. Transcatheter Mitral Valve Repair Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Transcatheter Mitral Valve Repair Devices Market Key Factors Analysis

  • 4.1. Transcatheter Mitral Valve Repair Devices Market Drivers
    • 4.1.1. Rising prevalence of heart valve diseases
    • 4.1.2. Increasing preference for minimally invasive surgeries
  • 4.2. Transcatheter Mitral Valve Repair Devices Market Restraints and Challenges
    • 4.2.1. Risks of post-operational complications
  • 4.3. Transcatheter Mitral Valve Repair Devices Market Opportunities
    • 4.3.1. Presence of a robust number of repair devices in the pipeline

5. Transcatheter Mitral Valve Repair Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Transcatheter Mitral Valve Repair Devices Market Layout

  • 6.1. By Type
    • 6.1.1. Mechanical Valve
    • 6.1.2. Bioprosthetic Tissue (Biological) Valve
  • 6.2. By Indication
    • 6.2.1. Mitral Valve Regurgitation
    • 6.2.2. Mitral Valve Stenosis
    • 6.2.3. Others
  • 6.3. By End-User
    • 6.3.1. Hospitals & Clinics
    • 6.3.2. Ambulatory Surgical Centers
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North America
      • 6.4.1.1. United States Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
    • 6.4.2. Europe
      • 6.4.2.1. France Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific
      • 6.4.3.1 China Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.3.3. India Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia-Pacific Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW)
      • 6.4.4.1. Middle East Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Transcatheter Mitral Valve Repair Devices Market Size in USD million (2021-2030)

7. Transcatheter Mitral Valve Repair Devices Market Company and Product Profiles

  • 7.1. Abbott
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Edwards Lifesciences Corporation.
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Shockwave Medical, Inc.
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. LivaNova PLC
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. NeoChord, Inc.
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Coramaze Technologies
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. CryoLife, Inc.
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Auto Tissue Berlin GmbH.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Medtronic
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Boston Scientific Corporation
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. JenaValve Technology, Inc
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Transcatheter mitral valve repair Devices Market in Global (2021-2030)
  • Table 4: Transcatheter mitral valve repair Devices Market in Global by Type (2021-2030)
  • Table 5: Transcatheter mitral valve repair Devices Market in Global by Indication (2021-2030)
  • Table 6: Transcatheter mitral valve repair Devices Market in Global by End-User (2021-2030)
  • Table 7: Transcatheter mitral valve repair Devices Market in Global by Geography (2021-2030)
  • Table 8: Transcatheter mitral valve repair Devices Market in North America (2021-2030)
  • Table 9: Transcatheter mitral valve repair Devices Market in North America by Country (2021-2030)
  • Table 10: Transcatheter mitral valve repair Devices Market in the US (2021-2030)
  • Table 11: Transcatheter mitral valve repair Devices Market in Canada (2021-2030)
  • Table 12: Transcatheter mitral valve repair Devices Market in Mexico (2021-2030)
  • Table 13: Transcatheter mitral valve repair Devices Market in Europe (2021-2030)
  • Table 14: Transcatheter mitral valve repair Devices Market in Europe by Country (2021-2030)
  • Table 15: Transcatheter mitral valve repair Devices Market in France (2021-2030)
  • Table 16: Transcatheter mitral valve repair Devices Market in Germany (2021-2030)
  • Table 17: Transcatheter mitral valve repair Devices Market in the United Kingdom (2021-2030)
  • Table 18: Transcatheter mitral valve repair Devices Market in Italy (2021-2030)
  • Table 19: Transcatheter mitral valve repair Devices Market in Spain (2021-2030)
  • Table 20: Transcatheter mitral valve repair Devices Market in the Rest of Europe (2021-2030)
  • Table 21: Transcatheter mitral valve repair Devices Market in Asia-Pacific (2021-2030)
  • Table 22: Transcatheter mitral valve repair Devices Market in Asia-Pacific by Country (2021-2030)
  • Table 23: Transcatheter mitral valve repair Devices Market in China (2021-2030)
  • Table 24: Transcatheter mitral valve repair Devices Market in Japan (2021-2030)
  • Table 25: Transcatheter mitral valve repair Devices Market in India (2021-2030)
  • Table 26: Transcatheter mitral valve repair Devices Market in Australia (2021-2030)
  • Table 27: Transcatheter mitral valve repair Devices Market in South Korea (2021-2030)
  • Table 28: Transcatheter mitral valve repair Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 29: Transcatheter mitral valve repair Devices Market in the Rest of the World (2021-2030)
  • Table 30: Transcatheter mitral valve repair Devices Market in RoW by Region (2021-2030)
  • Table 31: Transcatheter mitral valve repair Devices Market in the Middle East (2021-2030)
  • Table 32: Transcatheter mitral valve repair Devices Market in Africa (2021-2030)
  • Table 33: Transcatheter mitral valve repair Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Transcatheter mitral valve repair Devices Market in Global (2021-2030)
  • Figure 4: Transcatheter mitral valve repair Devices Market in Global by Type (2021-2030)
  • Figure 5: Transcatheter mitral valve repair Devices Market in Global by Indication (2021-2030)
  • Figure 6: Transcatheter mitral valve repair Devices Market in Global by End-User (2021-2030)
  • Figure 7: Transcatheter mitral valve repair Devices Market in Global by Geography (2021-2030)
  • Figure 8: Transcatheter mitral valve repair Devices Market in North America (2021-2030)
  • Figure 9: Transcatheter mitral valve repair Devices Market in North America by Country (2021-2030)
  • Figure 10: Transcatheter mitral valve repair Devices Market in the US (2021-2030)
  • Figure 11: Transcatheter mitral valve repair Devices Market in Canada (2021-2030)
  • Figure 12: Transcatheter mitral valve repair Devices Market in Mexico (2021-2030)
  • Figure 13: Transcatheter mitral valve repair Devices Market in Europe (2021-2030)
  • Figure 14: Transcatheter mitral valve repair Devices Market in Europe by Country (2021-2030)
  • Figure 15: Transcatheter mitral valve repair Devices Market in France (2021-2030)
  • Figure 16: Transcatheter mitral valve repair Devices Market in Germany (2021-2030)
  • Figure 17: Transcatheter mitral valve repair Devices Market in the United Kingdom (2021-2030)
  • Figure 18: Transcatheter mitral valve repair Devices Market in Italy (2021-2030)
  • Figure 19: Transcatheter mitral valve repair Devices Market in Spain (2021-2030)
  • Figure 20: Transcatheter mitral valve repair Devices Market in the Rest of Europe (2021-2030)
  • Figure 21: Transcatheter mitral valve repair Devices Market in Asia-Pacific (2021-2030)
  • Figure 22: Transcatheter mitral valve repair Devices Market in Asia-Pacific by Country (2021-2030)
  • Figure 23: Transcatheter mitral valve repair Devices Market in China (2021-2030)
  • Figure 24: Transcatheter mitral valve repair Devices Market in Japan (2021-2030)
  • Figure 25: Transcatheter mitral valve repair Devices Market in India (2021-2030)
  • Figure 26: Transcatheter mitral valve repair Devices Market in Australia (2021-2030)
  • Figure 27: Transcatheter mitral valve repair Devices Market in South Korea (2021-2030)
  • Figure 28: Transcatheter mitral valve repair Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 29: Transcatheter mitral valve repair Devices Market in the Rest of the World (2021-2030)
  • Figure 30: Transcatheter mitral valve repair Devices Market in RoW by Region (2021-2030)
  • Figure 31: Transcatheter mitral valve repair Devices Market in the Middle East (2021-2030)
  • Figure 32: Transcatheter mitral valve repair Devices Market in Africa (2021-2030)
  • Figure 33: Transcatheter mitral valve repair Devices Market in South America (2021-2030)
  • Figure 34: Market Drivers
  • Figure 35: Market Barriers
  • Figure 36: Marker Opportunities
  • Figure 37: PORTER'S Five Force Analysis